Concert Pharmaceuticals
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Concert Pharmaceuticals sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
Concert Pharmaceuticals: 24 sponsored US clinical trials, none currently recruiting.
Concert Pharmaceuticals sponsors 24 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 24 completed. 2 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Health Volunteers, with 2 trials.
Top-decile sponsor footprint
Concert Pharmaceuticals ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
24 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
24 total, page 1 of 1
Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects
NCT05478772
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects
NCT05467709
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers
NCT05467696
Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543
NCT05468749
Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543
NCT05467722
A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers
NCT05192369
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)
NCT04797650
Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects
NCT04843540
Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects
NCT04743414
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04784533
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
NCT04518995
Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects
NCT04309643
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia
NCT04158687
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
NCT04092712
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
NCT03941548
Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers
NCT03880253
Food Effect Study of CTP-543 in Healthy Volunteers
NCT03880136
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
NCT03811912
Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers
NCT03830463
Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata
NCT03137381
Open-Label Crossover Study Comparing CTP-543 to Jakafi®
NCT02960945
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
NCT01487109
Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease
NCT01460199
Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499
NCT01328821
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 6 |
| Phase 3 | 2 |
Therapeutic Areas
How the Concert Pharmaceuticals early-phase archive is shaped
24 indexed studies, none listed as recruiting (0% open); 24 completed (100%).
Phase mix: 2 late (III/IV) vs 22 early (I/II) (early-phase heavy).
Top condition: Health Volunteers (2 trials), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Concert Pharmaceuticals: archived-pipeline peers nationwide
Peers matched on 24 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Concert Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 archived trials
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Concert Pharmaceuticals page
24 registered trials is a research-attention snapshot, not an endorsement of Concert Pharmaceuticals or any single study.
- None of Concert Pharmaceuticals's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Health Volunteers is the condition Concert Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Health Volunteers trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Concert Pharmaceuticals pipeline card: 24 registered trials from official public datasets.Report a data error.